Project Grant R35GM160478
Award Date 9/1/26
Completion Date 8/31/31
Dollars Obligated $374K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Oklahoma City, OK, USA
Similar Awards
- The National Institute of General Medical Sciences, part of the National Institutes of Health within the Department of Health and Human Services, awarded The University of Texas Southwestern Medical Center $488,525 on July 1, 2026, under the Biomedical Research and Research Training program (CFDA 93.859), a Project Grant (R35GM162011). The award funds evolution-guided studies of mitochondrial activities and the host response to infectious agents. The research characterizes newly identified...
- The National Institute of General Medical Sciences awarded The Wistar Institute of Anatomy and Biology $506,550 on March 1, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to support research on compartmentalization and discrimination of double-stranded RNA in the nucleus. The funded research explores fundamental biological principles governing how cells distinguish self from non-self RNA molecules, specifically examining the balance between sensing pathogenic...
- The National Institute of General Medical Sciences awarded the University of Oklahoma a Project Grant of $360,157 on September 1, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to develop and apply sulfenylcarbenes and sulfenylnitrenes as reagents for site-selective chemical transformations in drug discovery. The research addresses the slowdown in pharmaceutical development by expanding chemical space through scaffold hopping—transforming established drug...
- The National Institute of General Medical Sciences awarded The Ohio State University $410,893 on March 1, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to conduct genomics-accelerated discovery and biosynthesis research on phosphonic acid natural products. The project, identified as R35GM161629, runs through December 31, 2030, with performance at Columbus, Ohio. The research program aims to discover microbial natural products of chemotherapeutic value, establish...
- The National Institute of General Medical Sciences awarded Oregon State University $1.2 million on September 1, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to investigate novel regulatory mechanisms that control secondary metabolite biosynthesis in microorganisms. The funded research addresses the challenge of discovering and expressing biosynthetic gene clusters (BGCs) that produce bioactive natural products for drug development. The project tests two primary...
- Federal Project Grant Award Summary The Oklahoma Medical Research Foundation (OMRF) received a $787,710 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) effective September 1, 2025, with a completion date of August 31, 2027. This award funds fundamental research investigating the function and regulation of DNA replication origin firing factors, specifically focusing on the recruitment and...
- The National Institute of General Medical Sciences awarded the University of Florida $386,985 on July 23, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to conduct a five-year investigation into the structure-function relationships of single-stranded DNA (ssDNA) in biological systems. The research will develop methods to probe structured ssDNA in cells, with initial focus on two biomedically relevant lines of investigation. The first examines complex ssDNA...
- The National Institute of General Medical Sciences (NIGMS), through its Biomedical Research and Research Training program (CFDA 93.859), awarded a $355,584 Project Grant to the New Mexico Institute of Mining and Technology (New Mexico Tech) on August 18, 2023. This funding will support research to determine the biochemical basis and functional implications of the interaction between the proteins XRN2 and DDX23, and explore their cooperative role in regulating RNA-DNA hybrid structures...
- The National Institute of General Medical Sciences awarded the University of New Mexico $370,940 on August 22, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to develop high-throughput free energy computational methods for small molecule, peptide, and protein design in drug discovery and optimization. The project integrates enhanced sampling methods with multisite lambda dynamics (MSLD) to create MSLD++, a framework intended to overcome computational...
- The National Institute of General Medical Sciences awarded the University of Connecticut Health Center $423,352 on March 18, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to investigate dead cell-phagocyte interaction at the phagosomal interface. The award funds research using a proximity-labeling technique called PhagoP1 to profile protein compositions of dead-cell-containing phagosomes and decode death-associated cellular responses. The research applies this...